Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

In the past decade, the introduction of molecularly targeted agents and immune-checkpoint
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …

Background In 2013, the United States Preventive Services Taskforce instituted
recommendations for annual lung cancer screening (LCS) with low-dose chest CT imaging …

Background Criteria for low-dose CT scan lung cancer screening vary across guidelines.
Knowledge of the eligible pool across demographic groups can enable policy and …

Objectives. To reexamine the time required to provide the US Preventive Services Task
Force (USPSTF)–recommended preventive services to a nationally representative adult …

Lung cancer (LC) is the leading cause of cancer-related mortality worldwide, and early LC
diagnosis can significantly improve outcomes and survival rates in affected patients …

Simple Summary Lung cancer management continues to evolve with improvements in
survival across all stages. The review highlights the current data supporting screening and …

Lung cancer is the leading cause of cancer-related deaths worldwide, primarily because
most people present when the stage is too advanced to offer any reasonable chance of cure …

Objective Sublobar resection is frequently offered to patients with small, peripheral lung
cancers, despite the lack of outcome data from ongoing randomized clinical trials. Sublobar …

OBJECTIVE: Yunnan, China, is a central tobacco-producing region with a large smoking
population and an increasing incidence of lung cancer in recent years. This study aimed to …